Blog

The recent findings from a study conducted in Taiwan have sparked hope for glioblastoma patients and the broader cancer research community. Researchers demonstrated that a novel technique using...

In a significant breakthrough for cancer treatment, researchers in Taiwan have reported promising results from an early-stage trial using focused ultrasound to enhance chemotherapy delivery for...

Recent research presented at the 2026 Society of Thoracic Surgeons Annual Meeting has shed light on a critical aspect of lung cancer surgery, particularly for patients diagnosed with non-small cell...

The recent appointment of Kim Slusser, Ph.D., R.N., as the inaugural chief nurse executive (CNE) at the University of Texas MD Anderson Cancer Center marks a significant moment in cancer care....

In a significant breakthrough for brain tumor treatment, researchers from Empa and the HOCH Health Ostschweiz hospital network are developing innovative tiny particles known as nanozymes. These...

The journey through cancer treatment is often fraught with challenges, particularly when it comes to managing the side effects of therapies like chemotherapy. A recent study from the United Kingdom...

In a significant advancement for the field of oncology, researchers have developed a new risk model that helps predict long-term survival outcomes for patients undergoing esophagectomy due to...

In an exciting development for cancer diagnostics, Prelude Corporation has received FDA Breakthrough Device designation for its AidaBREAST test, a significant advancement in understanding and...

The National Comprehensive Cancer Network (NCCN) recently garnered recognition through various awards and publications that highlight their commitment to improving cancer treatment guidelines. This...

On April 29, 2026, a critical moment arrived for cancer patients and advocates as the FDA’s Oncologic Drugs Advisory Committee prepared to evaluate two promising new treatments: camizestrant and...

The recent study from the University of Georgia has shed light on a troubling issue: individuals residing in low-income neighborhoods are significantly less likely to receive essential cancer...

A recent study from the University of Georgia has uncovered a troubling reality: individuals living in low-income neighborhoods are significantly less likely to receive cancer screenings at federal...

Recent research utilizing the STS General Thoracic Surgery Database has unveiled a groundbreaking risk model that could significantly influence treatment decisions for patients undergoing...

In a groundbreaking development for early cancer detection, researchers at Johns Hopkins have unveiled a novel approach that could significantly change the landscape of oncology diagnostics. By...

Recent news has highlighted a troubling issue within the cancer research community: disruptions in federal funding are significantly slowing down critical studies aimed at developing new treatments...

The recent breakthrough in cancer research, as reported by Newswise, introduces atomically engineered nanozymes (AENs)—tiny, engineered tools designed to enhance our immune system's ability to fight...

The recent announcement from the National Comprehensive Cancer Network (NCCN) about updated prostate cancer screening guidelines marks a pivotal shift in how healthcare providers approach this common...

Recent updates in prostate cancer screening guidelines from the National Comprehensive Cancer Network (NCCN) mark a significant shift in how healthcare providers assess risk and detect this prevalent...

The recent development of atomically engineered nanozymes (AENs) marks a significant milestone in the intersection of nanotechnology and immunotherapy, presenting an exciting frontier for cancer...

Recent advancements in cancer treatment highlight the ongoing battle against one of the most challenging forms of cancer: pancreatic cancer. A recent study showcased the potential of an...